1099:HKG
Sinopharm Group Co Ltd
17,14 HK$
arrow_downward
-0,17%(-0,030) 1K
28-iyl, 13:21:35 (GMT+8) · HKD
search
Barcha belgilar
1K
5K
1O
6O
YBB
1Y
5Y
MAKS
| Belgi | Narxi | Oʻzgartirishlar | Dinamika (%) |
|---|
insights_auto1099 tikeri uchun statistika yaratilmoqda...
Ochish
17,12 HK$
Yuqori
17,32 HK$
Past
17,08 HK$
Bozor kapitali
53,49 mlrd
Oʻrtacha hajm
6,60 mln
Hajmi
1,13 mln
Dividend
4,61%
Choraklik dividendlar
0,20 HK$
Eks-dividend sanasi
16-iyn, 2025
P/E koeffitsiyenti
6,45
52 haftalik eng yuqori
22,34 HK$
52 haftalik eng past
15,28 HK$
Aksiya boʻyicha daromad
2,66 HK$
Muomaladagi aksiyalar
1,19 mlrd
Xodimlar soni
95 ming
Ochish
17,12 HK$
Yuqori
17,32 HK$
Past
17,08 HK$
Bozor kapitali
53,49 mlrd
Oʻrtacha hajm
6,60 mln
Hajmi
1,13 mln
Dividend
4,61%
Choraklik dividendlar
0,20 HK$
Eks-dividend sanasi
16-iyn, 2025
P/E koeffitsiyenti
6,45
52 haftalik eng yuqori
22,34 HK$
52 haftalik eng past
15,28 HK$
Aksiya boʻyicha daromad
2,66 HK$
Muomaladagi aksiyalar
1,19 mlrd
Xodimlar soni
95 ming
Yangiliklar
Internetdagi manbalardan
MarketBeat
·
11 daqiqa oldin
City (NASDAQ:CHCO) Reaches New 12-Month High on Analyst Upgrade
Moomoo
·
28 daqiqa oldin
Dow Jones Top Company Headlines at 1 AM ET: Meta Is Fighting a Mountain of Social-Media Lawsuits-at Just the Wrong Time | LVMH's ...
Finance Magnates
·
8 daqiqa oldin
S&P 500 Delivers Strongest Earnings Surge Since 2021: How ActivTrades Helps Traders Capitalize on the Trend
Investor's Business Daily
·
3 soat oldin
Dow Jones Futures: U.S.-Iran Peace Hopes Send Oil Prices Plunging; Nvidia, Micron, Sandisk, SpaceX, Tesla Sell Off
Profil
Sinopharm Group Co., Ltd. is a Chinese pharmaceutical company. The parent company of Sinopharm Group was Sinopharm Industrial Investment, a 51–49 joint venture of state-owned enterprise China National Pharmaceutical Group and civilian-run enterprise Fosun Pharmaceutical.
Its H shares were listed on the Hong Kong Stock Exchange in 2009, with its IPO price of HK$16 per share. Sinopharm Group's subsidiary Sinopharm CNMC and Sinopharm Accord served as the A share counterpart of the company. However, the A share of Sinopharm Group itself was unlisted.
Sinopharm Group was ranked 829th in 2016 Forbes Global 2000 list. Wikipedia
Sinopharm Group Co Ltd haqida
CEO-
Xodimlar soni94,9 ming
Asos solingan2003
Bosh ofislar-
SektorHealth care provider
Veb-saytsinopharm.com
AI kontentda xatolar boʻlishi mumkin. Batafsil